A 73-year-old man with history of prostatic adenocarcinoma radical prostatectomy underwent 99m Tc-MDP whole-body bone scan and subsequent 68 Ga-labeled prostate-specific membrane antigen (PSMA) ligand PET/CT for restaging due to a gradual rise of prostate-specific antigen levels. Whole-body bone scan showed two focal zones of slightly increased uptake in the right fronto-parietal and temporal bones.
CASE HISTORY
A 73-year-old man, with prostate cancer, who underwent radical prostatectomy 10 years ago, was referred to our center for whole-body bone scan with 99m Tc-methylene diphosphonate ( 99m Tc-MDP).His serum prostate-specific membrane antigen (PSA) value had risen gradually starting four years ago, with a PSA doubling-time of about one year. His last serum PSA was 2.56 ng/ml. Whole-body bone scan was performed with a dualhead Siemens gamma camera (e-cam), which showed two focal zones of increased tracer uptake in the skull (right fronto-parietal and temporal bones (Figure 1 ). Later, a 68 Ga-labeled prostate-specific membrane antigen (PSMA) ligand positron emission tomography/computed tomography (PET/CT) scan was performed, which showed two foci of tracer activity in the brain, localized in the right frontoparietal and temporal lobes (Figures 2 and 3 ). There was also a zone of increased activity in the left prostatic bed. Neurosurgery consultation was ordered for possibility of cranial surgery in order to excise the suspicious metastatic lesions. A brain CT scan was performed for surgery planning. The brain CT scan showed two focal round areas of homogenously increased enhancement in the right fronto-parietal and temporal lobes, which is typical of the appearance of meningioma, with no evidence of adjacent bone destruction (Figures 4, 5, 6 ). Thus, cranial surgery was cancelled and radiotherapy of the prostatic bed was planned.
DISCUSSION
PSMA is a cell surface protein with high expression in prostate carcinoma cells and also a variety of other malignant and benign tumors [1] [2] [3] . But despite its expression by subsets of various types of malignancies, PSMA is still considered to be highly sensitive and specific for detecting prostatic cells. 68 Ga-PSMA PET/CT scan is used for staging, restaging and treatment planning of patients with prostate cancer [4] [5] [6] . This case demonstrates that meningioma can be a false positive finding in either 99m Tc-MDP bone scan or 68 Ga-PSMA PET/CT scan.
There are few case reports of increased 68 Ga-PSMA uptake in meningioma that may be mistaken as a foci of metastasis. Brain MRI is useful in differential diagnosis and may confirm meningioma with typical MRI findings [7] . Meningiomas are among the most common tumors of the central nervous system. They consist about 19% of intracranial and 25% of spinal tumors [8] . They often contain steroid hormone receptors and the presence of progesterone receptors (PRs). Even in a small number of tumor cells, have been shown to be a favorable prognostic factor for meningioma [9, 10] . 68 Ga-PSMA PET/CT scan -skull, showing a mass in the right parieto-temporal region, which has low SUV(SUV max=1.83).
Fig 3.
68 Ga-PSMA PET/CT scan-skull, showing a small mass in the right fronto-parietal region. There are no histopathological studies, to-date, evaluating the presence of PSMA receptors in meningioma. This case report suggests that meningioma may express PSMA receptors, and it may be mistaken as brain metastasis in PSMA imaging. Histopathologic diagnosis is mandatory if MRI findings was not typical of meningioma [11] .
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